
Terray Therapeutics is an AI-powered biotechnology company focused on revolutionizing small molecule drug discovery. Their platform, tNova, uniquely integrates high-throughput chemical experimentation with computational analysis and generative AI. This approach emphasizes both wet lab science and AI to solve complex therapeutic challenges. Terray boasts an experimental dataset of over two billion binding measurements, growing by 300 million monthly, with each measurement supported by 25 independent data points for high-resolution quantitative data. Their closed-loop iteration cycle, completing in under a month, allows for rapid exploration of chemical space and experimental measurement of millions of molecules. Terray's internal pipeline targets immunology, and they partner with large pharma and biotech companies to apply their platform to a wide range of challenging targets and therapeutic areas.

Terray Therapeutics is an AI-powered biotechnology company focused on revolutionizing small molecule drug discovery. Their platform, tNova, uniquely integrates high-throughput chemical experimentation with computational analysis and generative AI. This approach emphasizes both wet lab science and AI to solve complex therapeutic challenges. Terray boasts an experimental dataset of over two billion binding measurements, growing by 300 million monthly, with each measurement supported by 25 independent data points for high-resolution quantitative data. Their closed-loop iteration cycle, completing in under a month, allows for rapid exploration of chemical space and experimental measurement of millions of molecules. Terray's internal pipeline targets immunology, and they partner with large pharma and biotech companies to apply their platform to a wide range of challenging targets and therapeutic areas.
What they do: AI-powered, chemistry-first platform (tNova / EMMI) for small-molecule drug discovery combining high-throughput experimental chemistry and generative AI
Data scale: Experimental dataset of over two billion target–ligand binding measurements, growing rapidly
Funding: Raised >$200M total; $120M Series B announced Oct 17, 2024
Focus areas: Internal immunology programs and partnered programs with large pharma
Small-molecule drug discovery, particularly challenging targets in immunology and partnered pharma programs.
2018
Biotechnology Research
120000000
Announced as an oversubscribed round; brought total equity financing to over $200M.
60000000
20000000
“Syndicate includes institutional and strategic investors (e.g., Bedford Ridge Capital, NVentures/NVIDIA, Madrona, Two Sigma Ventures, Digitalis Ventures, XTX Ventures, Goldcrest Capital, Alexandria Venture Investments)”
| Company |
|---|
Company Overview: Terray Therapeutics is a venture-backed biotechnology company led by pioneers and long-time leaders in artificial intelligence, synthetic chemistry, automation, and nanotechnology. We’re generating chemical data purpose-built to propel drug discovery into the information age — and we’re doing it on a larger scale and faster than has ever before been possible.
Our closed loop system generates precise chemical datasets at unrivaled scale that work seamlessly with AI to systematically map biochemical interactions between small molecules and causes of disease. Iterative cycles of virtual molecular design and experimentation power AI and machine learning models, which in turn guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise with every cycle, we can answer an unprecedented array of questions — deriving insights that enable us to predictably create drugs for patients in need.
Terray Therapeutics is seeking a highly independent, motivated, and creative protein biochemist to join our preclinical team. An ideal candidate will have full responsibility of protein quality control workflows and be a pivotal member in collaboration between our screening and assay development teams. Successful candidates will be expected to be familiar with basic physical properties of targets of interest (based on literature and experimental sources) and play a key role in protein engineering, initial assay development and optimization. This position offers a unique opportunity to have an independent role and be a pivotal part of a multidisciplinary team in the frontiers of drug discovery.
The Core Responsibilities Of This Job Will Be
Experience and Qualifications: Part of Terray’s success is nurtured by a hands-on work environment where everyone is accountable, vested in a vision of excellence, and actively taking part in the success of the business. Terray supports a positive work environment where employees can feel engaged, recognized and empowered to be creative.
Required Qualifications
They will exhibit the ability to work well under pressure to provide results in a short timeframe. The company is looking for a highly responsive, goal-oriented individual who will bring significant energy and drive to solve complex technical problems and help us achieve our mission to advance human health.
Compensation Details: $78,000 to $106,000 (annually) depending on experience; participation in the Company's option plan; 3% retirement safe harbor contribution; fully-paid medical, dental, vision, life and disability benefits.